KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Current Assets (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Current Assets for 16 consecutive years, with $136.6 million as the latest value for Q4 2025.

  • Quarterly Current Assets fell 8.2% to $136.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $136.6 million through Dec 2025, down 8.2% year-over-year, with the annual reading at $136.6 million for FY2025, 8.2% down from the prior year.
  • Current Assets for Q4 2025 was $136.6 million at Biolife Solutions, up from $126.6 million in the prior quarter.
  • The five-year high for Current Assets was $148.8 million in Q4 2024, with the low at $88.2 million in Q2 2024.
  • Average Current Assets over 5 years is $123.0 million, with a median of $125.8 million recorded in 2021.
  • The sharpest move saw Current Assets skyrocketed 340.62% in 2021, then fell 26.69% in 2024.
  • Over 5 years, Current Assets stood at $126.1 million in 2021, then grew by 9.81% to $138.5 million in 2022, then dropped by 12.89% to $120.6 million in 2023, then grew by 23.35% to $148.8 million in 2024, then decreased by 8.2% to $136.6 million in 2025.
  • According to Business Quant data, Current Assets over the past three periods came in at $136.6 million, $126.6 million, and $125.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.